Jpmorgan Chase & Co »

Cytek Biosciences shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Cytek Biosciences (CTKB) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Cytek Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cytek Biosciences held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytek Biosciences by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.3M 599k 5.54
2024-06-30 $3.4M 608k 5.58
2024-03-31 $573k 85k 6.71
2023-12-31 $1.3M 148k 9.12
2023-09-30 $763k 138k 5.52
2023-06-30 $1.2M 145k 8.54
2023-03-31 $824k 90k 9.19
2022-12-31 $697k 68k 10.21
2022-06-30 $615k 62k 10.00
2022-03-31 $538k 50k 10.77
2021-12-31 $162k 9.9k 16.31